Please login to the form below

Not currently logged in
Email:
Password:

Lutathera

This page shows the latest Lutathera news and features for those working in and with pharma, biotech and healthcare.

Novartis raises 2019 guidance as new products gather speed

Novartis raises 2019 guidance as new products gather speed

from new prostate cancer therapy Lutathera, Kisqali (ribociclib) for breast cancer and CAR-T Kymriah (tisagenlecleucel). ... Meanwhile, Lutathera’s contribution was only $3m more in the second quarter compared to the first three months of the year,

Latest news

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics